← Back to Search

Foam Dressing

ALLEVYN Non-Adhesive Dressing for Venous Leg Ulcers

N/A
Recruiting
Led By Hadar Lev-Tov, MD, MAS
Research Sponsored by Molnlycke Health Care AB
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up a maximum total treatment period of 44 days or until healed, whichever occurs first.
Awards & highlights

Study Summary

This trial studies the effectiveness of a special foam dressing in healing chronic leg ulcer wounds. Patients wear it for up to 6 weeks to see the progress of healing.

Who is the study for?
This trial is for adults over 18 with chronic, oozing venous leg ulcers. Eligible participants should have moderate to large wound exudate and a wound size between 3 cm2 to 30 cm2. They must not have an infected ulcer, known allergies to the dressing material, a wrap-around wound, or be in another specific study. Participants need normal blood flow as verified by certain pressure measurements and agree to compression therapy.Check my eligibility
What is being tested?
The trial is testing ALLEVYN Non-Adhesive dressings on individuals with chronic venous leg ulcers. The focus is on tracking healing progress over time up to six weeks or until the wound heals. Dressings will be changed weekly.See study design
What are the potential side effects?
Potential side effects may include skin irritation or allergic reactions related to the non-bordered foam dressing materials used in this clinical investigation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~a maximum total treatment period of 44 days or until healed, whichever occurs first.
This trial's timeline: 3 weeks for screening, Varies for treatment, and a maximum total treatment period of 44 days or until healed, whichever occurs first. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Injury wounds
Secondary outcome measures
Change in exudate amount over time
Change in exudate nature over time
Change in granulation tissue over time
+21 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Supportive Care with Non-Bordered Foam DressingExperimental Treatment1 Intervention
All Subjects will use a non-bordered foam dressing as the absorbent primary dressing.

Find a Location

Who is running the clinical trial?

Molnlycke Health Care ABLead Sponsor
55 Previous Clinical Trials
7,825 Total Patients Enrolled
Hadar Lev-Tov, MD, MASPrincipal InvestigatorUniversity of Miami
2 Previous Clinical Trials
177 Total Patients Enrolled

Media Library

ALLEVYN Non-Adhesive (Foam Dressing) Clinical Trial Eligibility Overview. Trial Name: NCT05608317 — N/A
Venous Leg Ulcer Research Study Groups: Supportive Care with Non-Bordered Foam Dressing
Venous Leg Ulcer Clinical Trial 2023: ALLEVYN Non-Adhesive Highlights & Side Effects. Trial Name: NCT05608317 — N/A
ALLEVYN Non-Adhesive (Foam Dressing) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05608317 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacant roles in this research endeavor for participants?

"Clinicaltrials.gov data indicates that this clinical trial is no longer actively recruiting participants. This research was initially posted on November 8th 2022 and last edited on the first of November in the same year, but luckily there are 1,088 other trials currently open for enrolment."

Answered by AI
~2 spots leftby Jul 2024